JW Pharmaceutical Corp Capital Reinvestment Ratio
JW Pharmaceutical Corp capital reinvestment ratio. JW Pharmaceutical Corp (001065) has a Capital Reinvestment Ratio of 0.11x as of June 2026, meaning it reinvests 0% of its operating cash flow (₩42.51 Billion) in capital expenditures (₩4.52 Billion). Check JW Pharmaceutical Corp (001065) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of JW Pharmaceutical Corp (2014–2025)
Capital reinvestment ratio of JW Pharmaceutical Corp from 2014 to 2025. This chart tracks JW Pharmaceutical Corp's Capital Reinvestment Ratio across 11 annual periods. Also explore net asset growth rate of JW Pharmaceutical Corp to track the company's year-over-year net asset growth rate.
JW Pharmaceutical Corp Capital Reinvestment Ratio by Year (2014–2025)
JW Pharmaceutical Corp capital reinvestment ratio by year from 2014 to 2025. For the full cash flow conversion analysis, see JW Pharmaceutical Corp cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.37x | ₩96.40 Billion | ₩36.12 Billion | ▲ +5.7% |
| 2024 | 0.35x | ₩79.39 Billion | ₩28.14 Billion | ▼ -24.1% |
| 2023 | 0.47x | ₩87.16 Billion | ₩40.71 Billion | ▲ +167.3% |
| 2022 | 0.17x | ₩56.76 Billion | ₩9.92 Billion | ▼ -57.6% |
| 2021 | 0.41x | ₩18.12 Billion | ₩7.47 Billion | ▲ +109.7% |
| 2020 | 0.20x | ₩63.05 Billion | ₩12.39 Billion | ▲ +17.5% |
| 2019 | 0.17x | ₩55.53 Billion | ₩9.28 Billion | ▲ +0.9% |
| 2018 | 0.17x | ₩52.11 Billion | ₩8.64 Billion | ▼ -26.1% |
| 2017 | 0.22x | ₩33.45 Billion | ₩7.50 Billion | ▼ -84.9% |
| 2016 | 1.49x | ₩6.74 Billion | ₩10.02 Billion | ▲ +56.2% |
| 2014 | 0.95x | ₩7.28 Billion | ₩6.93 Billion | — |